Explore evidence

Cervical cancer is a leading cause of cancer death among women of reproductive age.

Kenyacancer du col de l'utéruspublished 2024BMC women's healthPubMeddocument of 3 observations

57 %There was a 57% reduction in rotavirus-associated hospitalizations in the first year post-vaccine introduction in Kilifi.

Kenyarotaviruspublished 2020Clinical infectious diseases : an official publication of the Infectious Diseases Society europe_pmcdocument of 8 observations

45.5 %Among neonates, the prevalence of jaundice was 45.5% in G6PD c.202T heterozygotes.

Kenyajaundicepublished 2020Blood advancesPubMeddocument of 11 observations

11.5 odds_ratioStillbirth was associated with gestational diabetes mellitus (odds ratio 11.5, 95% confidence interval 2.5–52.6).

Kenyadiabète gestationnel · stillbirthobserved August 2018 to April 2019published 2021International journal of gynaecology and obstetrics: the official organ of the InternationPubMeddocument of 7 observations

2.78 %The prevalence of malaria among blood donations was 2.78%.

Kenyapaludismepublished 2026Global health, epidemiology and genomicsPubMeddocument of 3 observations

1.34 risk_ratioKnowing someone who had cervical cancer was associated with an adjusted risk ratio of 1.34 for screening in Kenya.

Kenyacancer du col de l'utérusobserved 2022-2023published 2025BMC public healthPubMeddocument of 8 observations

5.04 hazard_ratioPregnancy loss was 5-fold higher among women with moderate-to-severe depressive symptoms (adjusted hazard ratio 5.04, 95% confidence interval 2.44, 10.42).

Kenyamoderate-to-severe depressive symptoms · pregnancy losspublished 2023Paediatric and perinatal epidemiologyPubMeddocument of 8 observations

92.4 %The majority (92.4%) of the RT-PCR positive individuals were asymptomatic in the Coastal part of Kenya between 17th March 2020 and 30th June 2021.

KenyaCOVID-19observed 17th March 2020 to 30th June 2021published 2022Wellcome open researcheurope_pmcdocument of 10 observations

0.2 %STI prevalence was 0.2% for inguinal bubo syndrome among participants in the African Cohort Study.

KenyaSTIspublished 2021BMC public healthPubMeddocument of 10 observations

0.73 annual_incidence_rate_ratioFor every successive year since 2009, the risk of HIV infection declined with an annual incidence rate ratio of 0.73.

KenyaVIH/sidaobserved 2009published 2025AIDS and behaviorPubMeddocument of 5 observations

54 foldSeven days after the Ad26.ZEBOV booster, the antibody geometric mean concentration (GMC) increased 54-fold to 38,965 EU/mL.

Kenyamaladie à virus Ebolapublished 2023VaccinePubMeddocument of 2 observations

251 per_100000The HIV/AIDS mortality rate was 251 per 100,000 population.

KenyaVIH/sidaobserved 2019published 2022PloS onePubMeddocument of 8 observations

45 %The prevalence rate of cisplatin-induced nephrotoxicity in cervical cancer patients was 45%.

Kenyacancer du col de l'utéruspublished 2022Journal of oncology pharmacy practice : official publication of the International Society PubMeddocument of 4 observations

80 %80% of patients assessed for antiretroviral therapy (ART) initiation presented with ≥1 tuberculosis (TB) symptoms.

Kenyatuberculosepublished 2020BMJ openPubMeddocument of 12 observations

60.5 %Among neonates, the prevalence of jaundice was 60.5% in G6PD c.202T homo/hemizygotes.

Kenyajaundicepublished 2020Blood advancesPubMeddocument of 11 observations

12.5 %Each additional year of ART use reduced the likelihood of detection of HR-HPV by 10-15% among Kenyan women living with HIV.

Kenyainfection à HPV · VIH/sidapublished 2021International journal of STD & AIDSPubMeddocument of 5 observations

Short-term forecasting of malaria incidence was performed using state-space reconstruction.

Kenyapaludismepublished 2024Journal of global healthPubMeddocument of 4 observations

The national analysis showed a regional shift in the timelines from the mutant to wild-type crt genotype and similarly from the mutant (CVIET) to wild-type (CVMNK) microhaplotype, with the Coast occurring earlier in 2002, while Western Kenya the change occurred later in 2008.

Kenyapaludismeobserved 2002, 2008published 2025A scoping review of antimalarial drug resistance markers in Kenya (1987-2022): Toward a Naeurope_pmcdocument of 5 observations

86 %Among 71 treatment-naive men who have sex with men with HIV in the HIV Prevention Trials Network 075 study, 86% sought HIV care following a positive diagnosis.

KenyaVIH/sidaobserved 2015-2017published 2025AIDS patient care and STDsPubMeddocument of 3 observations

26 %NCD knowledge significantly improved post-training, with mean score increasing from 6.46 to 8.17 (p = 0.0002), representing a 26% increase.

Kenyadiabetes and hypertensionpublished 2026BMC health services researchPubMeddocument of 4 observations

2,850,000,000 inhabitantsIt was estimated that 2.85 billion people were exposed to some risk of Plasmodium vivax transmission in 2009.

Kenyapaludismeobserved 2009published 2010PLoS neglected tropical diseaseseurope_pmcdocument of 5 observationsDOI 10.1371/journal.pntd.0000774

19.5 %Psychotic symptoms were significantly more prevalent in women (19.5%) compared to men (13.6%) in the study population.

Kenyapsychotic symptomspublished 2019BMC PsychiatryOpenAlexdocument of 9 observationsDOI 10.1186/s12888-019-2118-3

3 monthsThe median time to death was 3 months among patients initiated on antiretroviral therapy in central Kenya.

KenyaVIH/sidapublished 2022BMC infectious diseasesPubMeddocument of 10 observations

44.4 %Mortality at 72 hours was 44.4% for InterceptorG2 in an experimental hut trial against pyrethroid-resistant Anopheles funestus in Siaya, Kenya.

Kenyapaludismepublished 2024Malaria journalPubMeddocument of 5 observations

19.9 %Tobacco use prevalence was 19.9% among males.

Kenyatobacco useobserved 2015published 2020The Pan African medical journalPubMeddocument of 26 observations